Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

TCT 514: Distribution of Vessel-Specific Myocardial Mass in Patients With Stable Coronary Artery Disease

Presentation TCT 2024

TCT 514: Distribution of Vessel-Specific Myocardial Mass in Patients With Stable Coronary Artery Disease

Presenter: Bouisset Frederic

October 28, 2024

TCT 517: Photon-Counting CT in Patients With Coronary Stents and Recurrent Stable Angina: Direct Comparison With Perfusion Imaging by H2O-15-PET and Invasive Assessment: Initial Experiences

Presentation TCT 2024

TCT 517: Photon-Counting CT in Patients With Coronary Stents and Recurrent Stable Angina: Direct Comparison With Perfusion Imaging by H2O-15-PET and Invasive Assessment: Initial Experiences

Presenter: Søren Scheuer

October 28, 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.